Emergent BioSolutions Inc. - Common Stock (EBS)

Historical Holders from Q1 2014 to Q3 2025

Symbol
EBS on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
54.5M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
41.7M
Holdings value
$352M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
167
Number of buys
83
Number of sells
-83
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Emergent BioSolutions Inc. - Common Stock (EBS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.3% $25.4M 3.98M BlackRock, Inc. 30 Jun 2025

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 41.7M $352M +$19.7M $8.82 167
2025 Q2 36M $230M +$8.63M $6.38 159
2025 Q1 36.2M $176M +$2.18M $4.86 158
2024 Q4 34.7M $332M +$28.1M $9.56 155
2024 Q3 31.7M $265M +$31M $8.35 137
2024 Q2 30.4M $208M -$26.6M $6.82 137
2024 Q1 35.9M $90.8M -$12M $2.53 115
2023 Q4 40.9M $98.1M -$3.03M $2.40 129
2023 Q3 41.3M $141M -$26.3M $3.40 159
2023 Q2 45.7M $336M +$1.39M $7.35 177
2023 Q1 44.9M $465M -$16.9M $10.36 187
2022 Q4 46.2M $546M +$42.2M $11.81 193
2022 Q3 40.6M $853M -$48.6M $20.99 192
2022 Q2 41.2M $1.28B -$19.2M $31.04 217
2022 Q1 41.8M $1.71B -$22.6M $41.06 234
2021 Q4 42.5M $1.85B -$108M $43.47 243
2021 Q3 44.5M $2.23B -$18.4M $50.07 270
2021 Q2 44.7M $2.82B -$43.7M $62.99 286
2021 Q1 44.5M $4.12B +$64.7M $92.91 334
2020 Q4 44.3M $3.97B +$93.8M $89.60 350
2020 Q3 42.9M $4.43B -$190M $103.33 355
2020 Q2 53.5M $4.19B +$625M $79.08 295
2020 Q1 44.9M $2.6B +$7.89M $57.86 257
2019 Q4 44.6M $2.41B -$6.08M $53.95 232
2019 Q3 44.7M $2.34B -$21.9M $52.28 241
2019 Q2 45.5M $2.2B +$64.4M $48.31 229
2019 Q1 44.8M $2.27B +$80.9M $50.52 265
2018 Q4 43.1M $2.55B +$34.1M $59.28 293
2018 Q3 42.4M $2.79B +$14.9M $65.83 269
2018 Q2 42.6M $2.15B +$23.7M $50.49 257
2018 Q1 42.1M $2.21B +$57M $52.65 270
2017 Q4 40.4M $1.88B +$152M $46.47 234
2017 Q3 37.1M $1.5B +$64.4M $40.45 193
2017 Q2 35.6M $1.2B +$6.41M $33.91 179
2017 Q1 35.6M $1.03B +$100M $29.04 173
2016 Q4 35.7M $1.17B -$3.28M $32.84 204
2016 Q3 35.9M $1.13B -$1.49M $31.53 197
2016 Q2 36.2M $1.02B +$82.5M $28.12 215
2016 Q1 33.6M $1.22B +$19.1M $36.35 211
2015 Q4 32.4M $1.3B +$24.7M $40.01 202
2015 Q3 32.2M $917M +$35.7M $28.49 191
2015 Q2 31M $1.02B +$25.6M $32.95 181
2015 Q1 30.4M $874M +$38.1M $28.76 169
2014 Q4 29.1M $792M -$719K $27.23 163
2014 Q3 28.8M $615M -$30.7K $21.31 158
2014 Q2 28.7M $646M -$437K $22.46 157
2014 Q1 28.6M $722M +$89.5M $25.27 163